Skip to main content
. Author manuscript; available in PMC: 2020 Jan 29.
Published in final edited form as: Nature. 2018 Jul 25;560(7716):122–127. doi: 10.1038/s41586-018-0362-1

Extended Data Table 3. CRISPR-Cas9 reagents and edited cell-lines generated in this study. (A) Sequences of sgRNA used in gene editing experiments. S, indicates sgRNA corresponds to sense strand; AS, indicates antisense strand. (B) Individual edited alleles in each cell-line clone as confirmed by Sanger sequencing.

a
Target gene name / sgRNA # Sequence (5’-3’) Description
Rev7 (Mad2l2/Mad2b) CCTGATTCTCTATGTGCGCG Targeted to exon 4, S
C20orf196 / Shld1 1 CTGTACCTTGGATCTACCCG Targeted to exon 2, S
2 TCTTCTTCGACTACTGATCC Targeted to exon 2, S
Fam35a / Shld2 1 TCGGACTTTTTCCCAGGCGT Targeted to exon 4, AS
2 CAGGGAGTCAGACGAACTGA Targeted to exon 4, AS
3 ACTGCATGGACTAATATATC Targeted to exon 6, AS
Flj26957 / Shld3 1 GACTCATCGTATGGAAACCA Targeted to exon 1, AS
2 GGAAGTTTGGACTCATCGTA Targeted to exon 1, AS
b
CH12-F3 Target gene Clone Genotype
Allele 1 Allele 2
Rev7 C +1 bp at R34 -2 bp at R34
C20orf196 / Shld1 B2 +2 bp at L20 +2 bp at L20
C1 -14 bp at S54 +1 bp at D58
D1 -5 bp at T57 -5 bp at T57
Fam35a / Shld3 E4 -1 bp at A35 +32 bp at A35
F7 -25 bp at T32 -19 bp at N34
G11 -5 bp at R273 -20 bp at G270
Flj26957 / Shld3 A2 -1 bp at W46 -1 bp at W46
A4 - 2 bp at F42 -7 bp at I44
F9 -2 bp at Y49 -2 bp at Y49
H3 -4 bp at Y49 -13 bp at K53
Flj26957 in Rev7-/- (C) A2 -23 bp at F38 -23 bp at F38
C7 -22 bp at F38 -22 bp at F38
KB1P-G3 (Brca1-/- p53-/-) Flj26957 7 -1 bp at W46 -8 bp at W46
8 -1 bp at W46 -5 bp at W46